Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1752 | 2019 |
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent A Mazzoni, L Salvati, L Maggi, M Capone, A Vanni, M Spinicci, ... The Journal of clinical investigation 130 (9), 4694-4703, 2020 | 522 | 2020 |
The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection O Gallo, LG Locatello, A Mazzoni, L Novelli, F Annunziato Mucosal immunology 14 (2), 305-316, 2021 | 223 | 2021 |
Distinctive features of classic and nonclassic (T h17 derived) human T h1 cells L Maggi, V Santarlasci, M Capone, MC Rossi, V Querci, A Mazzoni, ... European journal of immunology 42 (12), 3180-3188, 2012 | 146 | 2012 |
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 A Mazzoni, N Di Lauria, L Maggi, L Salvati, A Vanni, M Capone, ... The Journal of clinical investigation 131 (12), 2021 | 127 | 2021 |
Demethylation of the RORC2 and IL17A in human CD4+ T lymphocytes defines Th17 origin of nonclassic Th1 cells A Mazzoni, V Santarlasci, L Maggi, M Capone, MC Rossi, V Querci, ... The Journal of Immunology 194 (7), 3116-3126, 2015 | 95 | 2015 |
Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production L Maggi, G Montaini, A Mazzoni, B Rossettini, M Capone, MC Rossi, ... Journal of Allergy and Clinical Immunology 139 (3), 964-976. e4, 2017 | 90 | 2017 |
IL‐4‐induced gene 1 maintains high T ob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells V Santarlasci, L Maggi, A Mazzoni, M Capone, V Querci, MC Rossi, ... European journal of immunology 44 (3), 654-661, 2014 | 87 | 2014 |
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab G Meoni, V Ghini, L Maggi, A Vignoli, A Mazzoni, L Salvati, M Capone, ... PLoS Pathogens 17 (2), e1009243, 2021 | 86 | 2021 |
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study AM Vannucchi, B Sordi, A Morettini, C Nozzoli, L Poggesi, F Pieralli, ... Leukemia 35 (4), 1121-1133, 2021 | 79 | 2021 |
Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation F Liotta, V Querci, G Mannelli, V Santarlasci, L Maggi, M Capone, ... British journal of cancer 112 (4), 745-754, 2015 | 74 | 2015 |
Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients A Mazzoni, L Maggi, M Capone, M Spinicci, L Salvati, MG Colao, A Vanni, ... European Journal of Immunology 50 (12), 2013-2024, 2020 | 69 | 2020 |
Eomes controls the development of Th17‐derived (non‐classic) Th1 cells during chronic inflammation A Mazzoni, L Maggi, F Siracusa, M Ramazzotti, MC Rossi, V Santarlasci, ... European journal of immunology 49 (1), 79-95, 2019 | 68 | 2019 |
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS‐CoV‐2 infection B Peruzzi, S Bencini, M Capone, A Mazzoni, L Maggi, L Salvati, A Vanni, ... Immunology 161 (4), 345-353, 2020 | 67 | 2020 |
Prompt predicting of early clinical deterioration of moderate-to-severe COVID-19 patients: usefulness of a combined score using IL-6 in a preliminary study A Vultaggio, E Vivarelli, G Virgili, E Lucenteforte, A Bartoloni, C Nozzoli, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2575-2581. e2, 2020 | 66 | 2020 |
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion A Mazzoni, L Salvati, L Maggi, F Annunziato, L Cosmi Seminars in Immunology 55, 101508, 2021 | 55 | 2021 |
Biological and clinical significance of T helper 17 cell plasticity A Mazzoni, L Maggi, F Liotta, L Cosmi, F Annunziato Immunology 158 (4), 287-295, 2019 | 52 | 2019 |
Th17 and Th1 lymphocytes in oligoarticular juvenile idiopathic arthritis L Maggi, A Mazzoni, R Cimaz, F Liotta, F Annunziato, L Cosmi Frontiers in immunology 10, 450, 2019 | 47 | 2019 |
Omalizumab dampens type 2 inflammation in a group of long‐term treated asthma patients and detaches IgE from FcεRI L Maggi, B Rossettini, G Montaini, A Matucci, A Vultaggio, A Mazzoni, ... European journal of immunology 48 (12), 2005-2014, 2018 | 46 | 2018 |
SARS-CoV-2 spike-specific CD4+ T cell response is conserved against variants of concern, including omicron A Mazzoni, A Vanni, M Spinicci, M Capone, G Lamacchia, L Salvati, ... Frontiers in Immunology 13, 801431, 2022 | 37 | 2022 |